東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

SARS-CoV-2 spike protein convergent ...

Focosi, Daniele.

FindBook

Google Book

Amazon

博客來

SARS-CoV-2 spike protein convergent evolution = impact of virus variants on efficacy of COVID-19 therapeutics and vaccines /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	SARS-CoV-2 spike protein convergent evolution/ by Daniele Focosi.
其他題名:	impact of virus variants on efficacy of COVID-19 therapeutics and vaccines /
作者:	Focosi, Daniele.
出版者:	Cham :Springer International Publishing : : 2021.,
面頁冊數:	xiii, 136 p. :ill., digital ;24 cm.
內容註:	Chapter 1. Why the Spike protein is relevant for COVID19 therapeutics -- Chapter 2. SARS-CoV-2 variants -- Chapter 3. Conclusion.
Contained By:	Springer Nature eBook
標題:	COVID-19 (Disease) -
電子資源:	https://doi.org/10.1007/978-3-030-87324-0
ISBN:	9783030873240

SARS-CoV-2 spike protein convergent evolution = impact of virus variants on efficacy of COVID-19 therapeutics and vaccines /
Focosi, Daniele.

SARS-CoV-2 spike protein convergent evolutionimpact of virus variants on efficacy of COVID-19 therapeutics and vaccines /[electronic resource] :by Daniele Focosi. - Cham :Springer International Publishing :2021. - xiii, 136 p. :ill., digital ;24 cm. - SpringerBriefs in microbiology,2191-5393. - SpringerBriefs in microbiology..

Chapter 1. Why the Spike protein is relevant for COVID19 therapeutics -- Chapter 2. SARS-CoV-2 variants -- Chapter 3. Conclusion.

This book reviews the current knowledge of the globally circulating SARS-CoV-2 variants, highlights their distinct genetic characteristics and associated conformational changes in the viral spike protein, and profoundly discusses the mechanisms of convergent evolution that led to the rise of these mutated strains at different geographic regions during the Covid-19 pandemic. Furthermore, the book explores how these variants do and may impact the efficacy of established neutralizing antibody-based (nAb) vaccines and therapeutics by analysing latest in vivo and in vitro clinical data. Finally, the author discusses ways on how nAb Covid-19 treatment derived immune escape of SARS-CoV-2 could be minimized in the future.

ISBN: 9783030873240

Standard No.: 10.1007/978-3-030-87324-0doiSubjects--Topical Terms:

3473310
COVID-19 (Disease)

LC Class. No.: RA644.C67

Dewey Class. No.: 614.592414

National Library of Medicine Call No.: QW 168.5.C8

SARS-CoV-2 spike protein convergent evolution = impact of virus variants on efficacy of COVID-19 therapeutics and vaccines /
LDR:01992nmm a2200349 a 4500 001 2253365
003 DE-He213
005 20211011061046.0
006 m d
007 cr nn 008maaau
008 220327s2021 sz s 0 eng d
020 $a 9783030873240 $q (electronic bk.)
020 $a 9783030873233 $q (paper)
024 7 $a 10.1007/978-3-030-87324-0 $2 doi
035 $a 978-3-030-87324-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RA644.C67
060 4 $a QW 168.5.C8
072 7 $a MMFM $2 bicssc
072 7 $a MED052000 $2 bisacsh
072 7 $a MKFM $2 thema
082 0 4 $a 614.592414 $2 23
090 $a RA644.C67 $b F652 2021
100 1 $a Focosi, Daniele. $3 3200476
245 1 0 $a SARS-CoV-2 spike protein convergent evolution $h [electronic resource] : $b impact of virus variants on efficacy of COVID-19 therapeutics and vaccines / $c by Daniele Focosi.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a xiii, 136 p. : $b ill., digital ; $c 24 cm.
490 1 $a SpringerBriefs in microbiology, $x 2191-5393
505 0 $a Chapter 1. Why the Spike protein is relevant for COVID19 therapeutics -- Chapter 2. SARS-CoV-2 variants -- Chapter 3. Conclusion.
520 $a This book reviews the current knowledge of the globally circulating SARS-CoV-2 variants, highlights their distinct genetic characteristics and associated conformational changes in the viral spike protein, and profoundly discusses the mechanisms of convergent evolution that led to the rise of these mutated strains at different geographic regions during the Covid-19 pandemic. Furthermore, the book explores how these variants do and may impact the efficacy of established neutralizing antibody-based (nAb) vaccines and therapeutics by analysing latest in vivo and in vitro clinical data. Finally, the author discusses ways on how nAb Covid-19 treatment derived immune escape of SARS-CoV-2 could be minimized in the future.
650 0 $a COVID-19 (Disease) $3 3473310
650 0 $a Medical virology. $3 661561
650 1 4 $a Virology. $3 642304
650 2 4 $a Immunology. $3 611031
650 2 4 $a Medical Microbiology. $3 890951
650 2 4 $a Microbial Genetics and Genomics. $3 891163
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a SpringerBriefs in microbiology. $3 1567364
856 4 0 $u https://doi.org/10.1007/978-3-030-87324-0
950 $a Biomedical and Life Sciences (SpringerNature-11642)